Subscribe to RSS
DOI: 10.1055/s-2003-38347
Straightforward Synthesis of N-Hydroxy Peptides
Publication History
Publication Date:
28 March 2003 (online)

Abstract
N-Hydroxy dipeptides are readily synthesized by reduction of the corresponding oximes. The two diastereomers obtained are easily separated by flash chromatography. They can be coupled with a third amino acid moiety - without protection of the hydroxyl group - to give N-hydroxy tripeptides.
Key words
N-hydroxy peptides - oximes - reduction - hydroxylamines - N-/O-acylation
- For reviews see:
-
1a
Ottenheijm HCJ.Herscheid JDM. Chem. Rev. 1986, 86: 697 -
1b
Marraud M.Vanderesse R. In Houben-Weyl, Methods of Organic Chemistry 4th ed., Vol. E22c:Goodman M. Thieme; Stuttgart: 2002. -
2a Isolation
and structure determination:
Umezawa K.Nakazawa K.Ikeda Y.Naganawa H.Kondo S. J. Org. Chem. 1999, 64: 3034 -
2b Biosynthesis of polyoxypeptin A:
Umezawa K.Ikeda Y.Kawase O.Naganawa H.Kondo S. J. Chem. Soc., Perkin Trans. 1 2001, 1550 -
3a
Garrouste P.Pawlowski M.Tonnaire T.Sicsic S.Dumy P.de Rosny E.Reboud-Ravaux M.Fulcrand P.Martinez J. Eur. J. Med. Chem. 1998, 33: 423 -
3b
Marastoni M.Bazzaro M.Salvadori S.Bortolotti F.Tomatis R. Bioorg. Med. Chem. 2001, 9: 939 -
4a
Dupont V.Lecoq A.Mangeot J.-P.Aubry A.Boussard G.Marraud M. J. Am. Chem. Soc. 1993, 115: 8898 -
4b
Takeuchi Y.Marshall GR. J. Am. Chem. Soc. 1998, 120: 5363 - Selected examples:
-
5a
Akiyama M.Katoh A.Mutsui Y.Watanabe Y.Umemoto K. Chem. Lett. 1996, 915 -
5b
Hara Y.Akiyama M. J. Am. Chem. Soc. 2001, 123: 7247 - 6
Kolosa T.Chimiak A. Tetrahedron 1977, 33: 3285 - Formation of the N-benzyloxy amide link is very sensitive to steric hindrance and generally requires strong acylating systems such as HATU {N-[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene]-N-methylmethan-aminium hexafluorophosphate} see:
-
7a
Akiyama M.Iesaki K.Katoh A.Shimizu K. J. Chem. Soc., Perkin Trans. 1 1986, 851 -
7b
Bianco A.Zabel C.Walden P.Jung G. J. Peptide Sci. 1998, 4: 471 -
8a Nucleophilic
substitution on α-bromo acid:
Kolasa T.Chimiak A. Tetrahedron 1974, 30: 3591 -
8b Use of α-hydroxy
acid via the triflate derivative:
Feenstra RW.Stokkingreef EHM.Nivard RJF.Ottenheijm HCJ. Tetrahedron 1988, 44: 5583 -
8c Under Mitsunobu conditions:
Hanessian S.Yang R.-Y. Synlett 1995, 633 -
8d Oxyamination of N-acylsultam enolate:
Oppolzer W.Tamura O.Deerberg J. Helv. Chim. Acta 1992, 75: 1965 -
8e Oxidation of α-amino
acid derivatives:
Grundke G.Keese W.Rimpler M. Synthesis 1987, 1115 -
8f See also:
Feenstra RW.Stokkingreef EHM.Reichwein AM.Lousberg WBH.Ottenheijm HCJ. Tetrahedron 1990, 46: 1745 -
8g See also:
Detomaso A.Curci R. Tetrahedron Lett. 2001, 42: 755 - 9
Ottenheijm HCJ.de Man JHM. Synthesis 1975, 163 - 11
Tijhuis MW.Herscheid JDM.Ottenheijm HCJ. Synthesis 1980, 890 - 12 Reduction of 2h with
sodium cyanoborohydride was also inefficient
-
19a Preparation
of DMTMM:
Kunishima M.Kawachi C.Morita J.Terao K.Iwasaki F.Tani S. Tetrahedron 1999, 55: 13159 -
19b Use in the synthesis of
hydroxamates:
De Luca L.Giacomelli G.Taddei M. J. Org. Chem. 2001, 66: 2534 -
20a Reaction
of N-alkyl hydroxylamine with mixed anhydrides
of amino acids:
Nakonieczna L.Chimiak A. Synthesis 1987, 418 -
20b Acylation of optically
active N-hydroxy Leucine methyl ester
with simple acyl chlorides:
Jin Y.Kim DH. Tetrahedron: Asymmetry 1997, 8: 3699
References
The two oxime isomers are separated by liquid chromatography. No difference in diastereoselectivity was observed in their reduction so that they were used as a mixture.
13All new compounds gave spectroscopic
and analytical data in agreement with the assigned structures. Selected
example: N-hydroxy dipeptide (S,S)-3b: [α]D
25 -3.8
(c 2.26, CHCl3). 1H
NMR (300 MHz, CDCl3): δ = 7.08
(d, 3
J = 9.6
Hz, 1 H, CONH), 5.46 (br, 2 H, NHOH), 4.61 (dd, 3
J = 9.6 and
4.8 Hz, H, CHα Val), 4.21 (m,
2 H, OCH
2CH3),
3.66 (q, 3
J = 7.1 Hz,
1 H, CHα Ala), 2.23 (m, 1 H,
CH-i-Pr),
1.29 (t, 3
J = 7.0 Hz,
3 H, OCH2CH
3),
1.26 (d, 3
J = 7.1
Hz, 3 H, CH
3 Ala), 0.97 (d, 3
J = 6.9 Hz,
3 H, CH
3-i-Pr),
0.91 (d, 3
J = 6.9
Hz, 3 H, CH
3-i-Pr). 13C
NMR (75.5 MHz, CDCl3): δ = 174.0, 172.8,
62.2, 61.6, 56.7, 31.2, 19.2, 17.7, 15.6, 14.3. MS (CI): m/z = 233
(100, M + H+), 187 (60), 159 (53).
IR (KBr,
cm-1): 3323 (m),
3254 (w), 2977 (m), 1738 (s), 1663 (s), 1541 (s).
Typical example: reduction of 9.33 mmol of 2b gave after flash chromatography (silica gel; CH2Cl2-MeOH, 97:3) 3.82 mmol of the first diastereomer, 0.53 mmol of a 1:1 mixture (estimated from 1H NMR) and 3.69 mmol of the second diastereomer.
15See ref. 1 and references therein.
16Compound (S,S,S)-4 {Fmoc-Ala1Ψ[CO(NOH)]Ala2Val3-OEt}: [α]D 25 -12.7 (c 1.28, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 8.94 (s, 1 H, OH), 7.73 (d, 3 J = 7.4 Hz, 2 H, CHar Fmoc), 7.58 (d, 3 J = 7.4 Hz, 2 H, CHar Fmoc), 7.37 (dd, 3 J = 7.4 and 7.4Hz, 2 H, CHar Fmoc), 7.27 (dd, 3 J = 7.4 and 7.4 Hz, 1 H, CHar Fmoc), 7.27 (dd, 3 J = 7.4 and 7.4 Hz, 1 H, CHar Fmoc), 7.16 (br d, 3 J = 8.7 Hz, 1 H, NH Val3), 5.96 (d, 3 J = 7.0 Hz, 1 H, NH Ala1), 5.29 (q, 3 J = 7.0 Hz, 1 H, CHα Ala2), 4.97 (dq, 3 J = 7.0 and 6.8 Hz, 1 H, CHα Ala1), 4.50 (dd, 3 J = 8.7 and 4.9 Hz, 1 H, CHα Val3), 4.38-4.27 (m, 2 H, CHH and CH Fmoc), 4.23-4.16 (m, 1 H, CHH Fmoc), 4.17 (q, 3 J = 7.1 Hz, 2 H, OCH 2CH3), 2.21-2.09 (m, 1 H, CH-i-Pr Val3), 1.49 (d, 3 J = 7.0 Hz, 3 H, CH 3 Ala2), 1.42 (d, 3 J = 6.8 Hz, 3 H, CH 3 Ala1), 1.23 (t, 3 J = 7.1 Hz, 3 H, OCH2CH 3), 0.91 (d, 3 J = 6.9 Hz, 3 H, CH 3-i-Pr Val3), 0.88 (d, 3 J = 6.9 Hz, 3 H, CH 3-i-Pr Val3). 13C NMR (50 MHz, CDCl3): δ = 172.8, 172.3, 171.7, 156.4, 143.9, 141.4, 127.8, 127.2, 125.3, 120.1, 67.4, 61.6, 57.3, 54.3, 47.2, 47.2, 31.5, 19.0, 18.2, 17.8, 14.5, 14.3. MS (CI): m/z = 543 (27, M + NH4 +) 304 (100), 179 (69). IR (KBr, cm-1): 3316 (s br), 2964 (m), 1734 (s), 1701 (s), 1641 (s), 1533 (s), 1450 (s).
17Selected 1H NMR data (250 MHz, CDCl3) for compound 5: δ = 7.42 (br d, 3 J = 4.5 Hz, 1 H, -NH-O-CO-), 3.73 [qd, 3 J = 6.9 and 4.5 Hz, 1 H, -CH(CH3)-NH-O(CO)-].
18Abbreviations: DCC, dicyclohexylcarbodiimide; HOBt, 1-hydroxybenzotriazole; EDCI, 1-ethyl-3-(3′-dimethyl-aminopropyl)carbodiimide; BOP, benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluoro-phosphate; DMTMM, 4-(4, 6-dimethoxy[1,3,5]triazin-2-yl)-4-methyl-morpholinium chloride.
21Running the reaction in CDCl3 in a NMR tube with 3 equiv of pyridine indicates that with 0.7 equiv of TMSCl two exchanging products are first visible. After the addition of an excess TMSCl (up to 2.2 equiv), only one product remains. This is in agreement with previous findings (see ref. 20a).